Notice of Correction to RFA-CA-17-012 "Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)"

Notice Number: NOT-CA-17-074

Key Dates
Release Date:  July 6, 2017

Related Announcements
RFA-CA-17-012

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to add a correction to RFA-CA-17-012 "Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)".

Part 1. Overview Information

 

Currently reads:

Announcement Type: Reissue of RFA-CA-16-001

Modified to read (in italics)

Announcement Type: Reissue of RFA-CA-16-003

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Tony Dickherber, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-547-9980
Email: dickherberaj@mail.nih.gov

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov